Mats Remberger

Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation

Moya, Tommy Alfaro; Carreira, Abel Santos; Chen, Shiyi; Remberger, Mats et al.

Ingår i PLOS ONE, 2025

• DOI för Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation
• Ladda ner fulltext (pdf) av Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation

Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation

Herrity, Elizabeth; Singhabahu, Sanjay; Remberger, Mats; Moya, Tommy Alfaro et al.

Ingår i Cancers, 2025

• DOI för Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation
• Ladda ner fulltext (pdf) av Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation

Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?

Alnughmush, Ahmed; Sayyed, Ayman; Remberger, Mats; AL-Shaibani, Eshrak et al.

Ingår i Transplantation direct, 2025

• DOI för Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?
• Ladda ner fulltext (pdf) av Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?

PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation

Desai, Nihar; Altareb, Majed; Remberger, Mats; Chen, Carol et al.

Ingår i Blood Advances, 2024

• DOI för PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation
• Ladda ner fulltext (pdf) av PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

Gronvold, B. Linder; Ali, Maryan Mohamed; Myklebust, Tor Å; Lenartova, Andrea et al.

Ingår i eJHaem, s. 117-124, 2024

• DOI för Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
• Ladda ner fulltext (pdf) av Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation

Moya, Tommy Alfaro; Carreira, Abel Santos; Chen, Shiyi; Remberger, Mats et al.

Ingår i PLOS ONE, 2025

• DOI för Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation
• Ladda ner fulltext (pdf) av Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation

Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation

Herrity, Elizabeth; Singhabahu, Sanjay; Remberger, Mats; Moya, Tommy Alfaro et al.

Ingår i Cancers, 2025

• DOI för Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation
• Ladda ner fulltext (pdf) av Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation

Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?

Alnughmush, Ahmed; Sayyed, Ayman; Remberger, Mats; AL-Shaibani, Eshrak et al.

Ingår i Transplantation direct, 2025

• DOI för Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?
• Ladda ner fulltext (pdf) av Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?

PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation

Desai, Nihar; Altareb, Majed; Remberger, Mats; Chen, Carol et al.

Ingår i Blood Advances, 2024

• DOI för PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation
• Ladda ner fulltext (pdf) av PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

Gronvold, B. Linder; Ali, Maryan Mohamed; Myklebust, Tor Å; Lenartova, Andrea et al.

Ingår i eJHaem, s. 117-124, 2024

• DOI för Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
• Ladda ner fulltext (pdf) av Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study

Pasic, Ivan; Moya, Tommy Alfaro; Remberger, Mats; Chen, Carol et al.

Ingår i Transplantation and Cellular Therapy, s. 6810-68100000000000, 2024

• DOI för Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study

Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data

Pang, Ian; Chen, Peggy; Trinh, Gertrude V.; Remberger, Mats et al.

Ingår i European Journal of Haematology, s. 301-309, 2024

• DOI för Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Gerbitz, Armin; Gary, Regina; Aigner, Michael; Moosmann, Andreas et al.

Ingår i Frontiers in Immunology, 2023

• DOI för Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study
• Ladda ner fulltext (pdf) av Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Pereira, Mariana Pinto; Remberger, Mats; Chen, Carol; Gerbitz, Armin et al.

Ingår i Transplantation and Cellular Therapy, 2023

• DOI för Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation

Carreira, Abel Santos; Salas, Maria Queralt; Remberger, Mats; Novitzky-Basso, Igor et al.

Ingår i Transplantation and Cellular Therapy, s. 5810-58100000000, 2023

• DOI för Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation

Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden

Schain, Frida; Boissin, Constance; Laczik, Tamas; Fedeli, Stefano et al.

Ingår i Transfusion and apheresis science, 2023

• DOI för Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden
• Ladda ner fulltext (pdf) av Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden

Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease

Novitzky-Basso, Igor; Schain, Frida; Batyrbekova, Nurgul; Webb, Thomas et al.

Ingår i PLOS ONE, 2023

• DOI för Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease
• Ladda ner fulltext (pdf) av Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease

COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis

Lim, Yeong Jer; Khan, Umair; Karpha, Indrani; Ross, Andrew et al.

Ingår i eJHaem, s. 862-872, 2022

• DOI för COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis
• Ladda ner fulltext (pdf) av COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis

Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study

Carreira, Abel Santos; Salas, Maria Queralt; Remberger, Mats; Basso, Igor Novitzky et al.

Ingår i Transplantation and Cellular Therapy, s. 500-5000000000, 2022

• DOI för Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study

Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation

Prem, Shruti; Remberger, Mats; Alotaibi, Ahmad; Lam, Wilson et al.

Ingår i Transplant Infectious Disease, 2022

• DOI för Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation

Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups

Garcia‐Horton, Alejandro; Cyriac, Sunu L.; Gedde‐Dahl, Tobias; Floisand, Yngvar et al.

Ingår i European Journal of Haematology, s. 672-679, 2022

• DOI för Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups

The impact of transportation time on apoptosis in allogeneic stem cell grafts and the clinical outcome in malignant patients with unrelated donors

Wang, Tengyu; Remberger, Mats; Bjorklund, Andreas; Watz, Emma

Ingår i Cytotherapy, s. 508-515, 2022

• DOI för The impact of transportation time on apoptosis in allogeneic stem cell grafts and the clinical outcome in malignant patients with unrelated donors
• Ladda ner fulltext (pdf) av The impact of transportation time on apoptosis in allogeneic stem cell grafts and the clinical outcome in malignant patients with unrelated donors

Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience

Salas, Maria Queralt; Pasic, Ivan; Remberger, Mats; Novitzky-Basso, Igor et al.

Ingår i Transplantation and Cellular Therapy, 2022

• DOI för Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience

Anti‐thymocyte Globulin and Post‐Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen‐A and ‐B mismatched donors

Novitzky‐Basso, Igor; Remberger, Mats; Chen, Carol; Ellison, Cynthia et al.

Ingår i European Journal of Haematology, s. 288-297, 2022

• DOI för Anti‐thymocyte Globulin and Post‐Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen‐A and ‐B mismatched donors

Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts

Novitzky‐Basso, Igor; Remberger, Mats; Chen, Carol; Pasić, Ivan et al.

Ingår i European Journal of Haematology, s. 61-72, 2021

• DOI för Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts
• Ladda ner fulltext (pdf) av Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts

Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival

Ali, M. M.; Gronvold, B.; Remberger, Mats; Abrahamsen, I. W. et al.

Ingår i Clinical Lymphoma, Myeloma & Leukemia, s. 598-605, 2021

• DOI för Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival

Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care

Ringdén, Olle; Remberger, Mats; Törlén, Johan; Finnbogadottir, Sigrun et al.

Ingår i International Journal of Hematology, s. 712-722, 2021

• DOI för Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care

Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease

Schain, Frida; Batyrbekova, Nurgul; Liwing, Johan; Baculea, Simona et al.

Ingår i European Journal of Health Economics, s. 169-180, 2021

• DOI för Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease
• Ladda ner fulltext (pdf) av Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease

Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG

Remberger, Mats; Tjønnfjord, Geir E.; Abrahamsen, Ingerid W.; Ali, Maryan et al.

Ingår i Transplantation and Cellular Therapy, s. 6210-621000, 2021

• DOI för Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG
• Ladda ner fulltext (pdf) av Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis

Garming-Legert, Karin; Ringdén, Olle; Remberger, Mats; Törlén, Johan et al.

Ingår i Oral Diseases, s. 1217-1225, 2020

• DOI för Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis
• Ladda ner fulltext (pdf) av Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis

Histopathological Grading of Oral Mucosal Chronic Graft-versus-Host Disease: Large Cohort Analysis

Tollemar, Victor; Tudzarovski, Nikcole; Warfvinge, Gunnar; Yarom, Naom et al.

Ingår i Biology of blood and marrow transplantation, s. 1971-1979, 2020

• DOI för Histopathological Grading of Oral Mucosal Chronic Graft-versus-Host Disease: Large Cohort Analysis
• Ladda ner fulltext (pdf) av Histopathological Grading of Oral Mucosal Chronic Graft-versus-Host Disease: Large Cohort Analysis

Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c⁺ Expression in Tumor

Magalhaes, Isabelle; Fernebro, Josefin; Abd Own, Sulaf; Glaessgen, Daria et al.

Ingår i Advances in Therapy, s. 5023-5031, 2020

• DOI för Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c⁺ Expression in Tumor
• Ladda ner fulltext (pdf) av Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c⁺ Expression in Tumor

The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors

Remberger, Mats; Grønvold, B.; Ali, M.; Mattsson, J. et al.

Ingår i Clinical Hematology International, s. 74-81, 2020

• DOI för The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors
• Ladda ner fulltext (pdf) av The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors

Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

Cheng, Guang‐Shing; Selwa, Katherine E.; Hatt, Charles; Ram, Sundaresh et al.

Ingår i American Journal of Transplantation, s. 2198-2205, 2020

• DOI för Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

Effect of donor age and kinship on outcomes in haplo-identical stem cell transplantation may be modulated by GVHD prophylaxis strategies

Prem, Shruti; Remberger, Mats; Salas, Maria Queralt; Al-Shaibani, Zeyad et al.

Ingår i Bone Marrow Transplantation, s. 689-691, 2020

• DOI för Effect of donor age and kinship on outcomes in haplo-identical stem cell transplantation may be modulated by GVHD prophylaxis strategies

Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation

El-Serafi, Ibrahim; Remberger, Mats; Ringdén, Olle; Törlén, Johan et al.

Ingår i Clinical and Translational Science, s. 293-300, 2020

• DOI för Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
• Ladda ner fulltext (pdf) av Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation

High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis

Queralt Salas, Maria; Prem, Shruti; Remberger, Mats; Lam, Wilson et al.

Ingår i Leukemia and Lymphoma, s. 3198-3208, 2020

• DOI för High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis

HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation

Grønvold, B.; Ali, M. M.; Remberger, Mats; Mattsson, J. et al.

Ingår i Bone Marrow Transplantation, s. 1658-1661, 2020

• DOI för HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation

Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease

Sadeghi, Behnam; Remberger, Mats; Gustafsson, Britt; Winiarski, Jacek et al.

Ingår i Biology of blood and marrow transplantation, s. 1965-1969, 2019

• DOI för Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease
• Ladda ner fulltext (pdf) av Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease

The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease

Svenberg, Petter; Wang, Tengyu; Uhlin, Michael; Watz, Emma et al.

Ingår i Clinical Transplantation, 2019

• DOI för The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female Donor

Ringden, Olle; Remberger, Mats; Gustafsson, Britt; Moretti, Gianluca et al.

Ingår i Transplantation, s. 1247-1252, 2019

• DOI för The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female Donor